With the analysis among 8,092 patents, we discovered top 469 key players by total patent application. Pfizer Inc., Merck Patent GmbH, CHIESI Farmaceutici SpA are dominant in this area. They take 14.84% of the total patent filing.
New York, United States
Patent: 682
Hessen, Germany
Patent: 269
Emilia-Romagna, Italy
Patent: 250
Connecticut, United States
Patent: 228
Washington, United States
Patent: 211
Memory Pharmaceuticals Corp.
New Jersey, United States
Patent: 181
Illinois, United States
Patent: 170
Hounslow, United Kingdom
Patent: 144
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 142
New Jersey, United States
Patent: 135
With the analysis among 138 patents, we discovered top 15 start-ups by total patent application. SyntheX, Inc., TOPADUR Pharma AG, Stingray Therapeutics, Inc. are active in this area.
California, United States
Patent: 48
ZURICH, Switzerland
Patent: 26
Stingray Therapeutics, Inc.
Texas, United States
Patent: 16
Washington, United States
Patent: 13
Volastra Therapeutics, Inc.
New York, United States
Patent: 9
Cyrano Therapeutics, Inc.
District of Columbia, United States
Patent: 8
Basel-Stadt, Switzerland
Patent: 6
New York, United States
Patent: 3
Obsidian Therapeutics, Inc.
Massachusetts, United States
Patent: 2
With the analysis among related 747 patents applied in the last 5 years. We discover 173 most active companies in this area. The fast-growing Intra-Cellular Therapies, Inc., Union Therapeutics A/S, TOPADUR Pharma AG take 12.45% of patent filing during this period.
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 42
Hovedstaden, Denmark
Patent: 26
ZURICH, Switzerland
Patent: 25
Actelion Pharmaceuticals Ltd.
Basel-Landschaft, Switzerland
Patent: 22
Ildong Pharmaceutical Co., Ltd.
Massachusetts, United States
Patent: 21
Illinois, United States
Patent: 20
Stingray Therapeutics, Inc.
Texas, United States
Patent: 16
Westfälische Wilhelms-Universität Münster
undefined undefined
Patent: 16
With the analysis among related 747 patents in last 5 years, we discover 100 new entrants. Actelion Pharmaceuticals Ltd., Ildong Pharmaceutical Co., Ltd., Stingray Therapeutics, Inc. are the most active new entrants in this area.
Actelion Pharmaceuticals Ltd.
Basel-Landschaft, Switzerland
Patent: 22
Ildong Pharmaceutical Co., Ltd.
Stingray Therapeutics, Inc.
Texas, United States
Patent: 16
California, United States
Patent: 14
California, United States
Patent: 10
Volastra Therapeutics, Inc.
New York, United States
Patent: 9
Aten Porus Lifesciences Pvt Ltd.
Karnataka, India
Patent: 7
Avammune Therapeutics, Inc.
Pennsylvania, United States
Patent: 6
Basel-Stadt, Switzerland
Patent: 6
Hangzhou Xingao Biotechnology Co., Ltd.
Zhejiang Sheng, China
Patent: 6
With the analysis among 675 patents, we discovered top 107 universities and scientific research institutions by total patent application. Sun Yat-Sen University, Shanghai Institute of Materia Medica Chinese Academy of Sciences, The Trustees of Columbia University in The City of New York are dominant in this area. They take 15.11% of the total patent filing.
Guangdong Sheng, China
Patent: 32
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 27
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 23
The Rockefeller University
New York, United States
Patent: 14
University of Santiago de Compostela
Asturias, Spain
Patent: 12
Universidad Pública de Navarra
Bern, Switzerland
Patent: 10
Julius-Maximilians-Universität Würzburg
Washington, United States
Patent: 8
The Johns Hopkins University